Rating History for CRISPR Therapeutics (CRSP) by Morgan Stanley
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/11/2026 | Maxwell Skor | New Coverage | Equalweight (N/A) |
60.00 (N/A) |
51.48 (53.99) |
4.88% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
